These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35613159)

  • 1. Chagas disease treatment: a 120-year-old challenge to public health.
    Goldenberg S
    Mem Inst Oswaldo Cruz; 2022; 117():e210501chgsa. PubMed ID: 35613159
    [No Abstract]   [Full Text] [Related]  

  • 2. Chagas Disease and Coumarins: A Review of Natural and Synthetic Coumarins As Anti-Trypanosoma Cruzi Agents.
    Gonçalves GA; Cerecetto H; Poser GLV; Canto RFS; Eifler-Lima VL
    Mini Rev Med Chem; 2021; 21(13):1701-1717. PubMed ID: 33372872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific chemotherapy of Chagas disease: controversies and advances.
    Urbina JA; Docampo R
    Trends Parasitol; 2003 Nov; 19(11):495-501. PubMed ID: 14580960
    [No Abstract]   [Full Text] [Related]  

  • 4. Trypanosoma cruzi infection of human induced pluripotent stem cell-derived cardiomyocytes: an in vitro model for drug screening for Chagas disease.
    da Silva Lara L; Andrade-Lima L; Magalhães Calvet C; Borsoi J; Lopes Alberto Duque T; Henriques-Pons A; Souza Pereira MC; Veiga Pereira L
    Microbes Infect; 2018 May; 20(5):312-316. PubMed ID: 29577969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease.
    Carmo AA; Rocha MO; Silva JL; Ianni BM; Fernandes F; Sabino EC; Ribeiro AL
    Int J Cardiol; 2015 Jun; 189():182-4. PubMed ID: 25897900
    [No Abstract]   [Full Text] [Related]  

  • 7. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
    Duschak VG
    Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Discovery for Paediatric Chagas Disease.
    Thota S; Morel CM
    Mini Rev Med Chem; 2018; 18(9):776-780. PubMed ID: 26202205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol metabolism in Trypanosoma cruzi: potential target for chemotherapy against Chagas' disease.
    Oliveira MM; Einicker-Lamas M
    An Acad Bras Cienc; 2000 Sep; 72(3):413-9. PubMed ID: 11028106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discovery for chagas disease: A viewpoint.
    Kratz JM
    Acta Trop; 2019 Oct; 198():105107. PubMed ID: 31351074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Chagas disease. New schemes].
    Apt W; Zulantay I; Salas P
    Rev Med Chil; 2022 Dec; 150(12):1689-1690. PubMed ID: 37906792
    [No Abstract]   [Full Text] [Related]  

  • 12. Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.
    Zingales B
    Acta Trop; 2018 Aug; 184():38-52. PubMed ID: 28941731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to identify new drug target for the treatment of Chagas disease.
    Lisvane Silva P; Mantilla BS; Barisón MJ; Wrenger C; Silber AM
    Curr Pharm Des; 2011; 17(20):2074-99. PubMed ID: 21718252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new chemotype with promise against Trypanosoma cruzi.
    Wang X; Cal M; Kaiser M; Buckner FS; Lepesheva GI; Sanford AG; Wallick AI; Davis PH; Vennerstrom JL
    Bioorg Med Chem Lett; 2020 Jan; 30(1):126778. PubMed ID: 31706668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
    N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chagas Disease: A Solvable Problem, Ignored.
    Tarleton RL
    Trends Mol Med; 2016 Oct; 22(10):835-838. PubMed ID: 27523778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
    Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity.
    Supuran CT
    Future Med Chem; 2016; 8(3):311-24. PubMed ID: 26898220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chagas disease challenge - New techniques for diagnosis and treatment address to control in endemic areas.
    Marins JRP
    Mem Inst Oswaldo Cruz; 2022; 117():e210033chgsb. PubMed ID: 35584510
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of a recombinant Trypanosoma cruzi protein antigen to monitor cure of Chagas disease.
    Guevara AG; Taibi A; Alava J; Guderian RH; Ouaissi A
    Trans R Soc Trop Med Hyg; 1995; 89(4):447-8. PubMed ID: 7570896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.